Viracta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

May 7, 2024

https://www.globenewswire.com/news-release/2024/05/07/2877207/0/en/Viracta-Therapeutics-to-Present-at-the-RBC-Capital-Markets-Global-Healthcare-Conference.html

SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) — Viracta Therapeutics, Inc. (Nasdaq:VIRX), a clinical-stage precision oncology company focused on the treatment and prevention of virus-associated cancers that impact patients worldwide, today announced that Mark Rothera, President and Chief Executive Officer, and Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer, are scheduled to participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 11:00 a.m. EDT.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.